Skip to main content

INCYTE CORP

For the period ended Mar 31, 2024. Filed Apr 30, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed Apr 30, 2024

INCY$121.89+1.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except number of shares and par value)

March 31,2024December 31,2023*
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents$3,346,204$3,213,376
Marketable securities—available-for-sale (amortized cost $506,379 and $442,816 as of March 31, 2024 and December 31, 2023, respectively; allowance for credit losses $0 as of March 31, 2024 and December 31, 2023)504,484442,667
Accounts receivable745,526743,557
Inventory63,64262,972
Prepaid expenses and other current assets189,235182,830
Total current assets4,849,0914,645,402
Restricted cash1,6271,845
Long term investments287,663187,716
Inventory264,292206,965
Property and equipment, net719,999751,513
Finance lease right-of-use assets, net25,53325,535
Other intangible assets, net117,841123,545
Goodwill155,593155,593
Deferred income tax asset666,566631,886
Other assets, net47,40052,107
Total assets$7,135,605$6,782,107
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$164,238$109,601
Accrued compensation89,109153,348
Accrued and other current liabilities1,102,268935,569
Finance lease liabilities3,6783,439
Acquisition-related contingent consideration37,16038,422
Total current liabilities1,396,4531,240,379
Acquisition-related contingent consideration164,840173,578
Finance lease liabilities28,93429,162
Other liabilities151,107149,151
Total liabilities1,741,3341,592,270
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; none issued or outstanding——
Common stock, $0.001 par value; 400,000,000 shares authorized; 224,533,449 and 224,286,862 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively224224
Additional paid-in capital5,070,2865,016,122
Accumulated other comprehensive (loss) income(6,172)13,106
Retained earnings329,933160,385
Total stockholders’ equity5,394,2715,189,837
Total liabilities and stockholders’ equity$7,135,605$6,782,107

*The condensed consolidated balance sheet at December 31, 2023 has been derived from the audited consolidated financial statements at that date.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.